Kayne Anderson Rudnick Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81M Sell
41,756
-1,793
-4% -$119K 0.01% 313
2026
Q1
$2.73M Sell
43,549
-1,110
-2% -$77.3K 0.01% 303
2025
Q4
$2.96M Sell
44,659
-2,839
-6% -$184K 0.01% 301
2025
Q3
$3.2M Sell
47,498
-2,962
-6% -$234K 0.01% 293
2025
Q2
$4.4M Sell
50,460
-1,447
-3% -$113K 0.01% 271
2025
Q1
$3.54M Sell
51,907
-2,403
-4% -$196K 0.01% 292
2024
Q4
$4.22M Buy
54,310
+22,458
+71% +$1.66M 0.01% 276
2024
Q3
$2.14M Sell
31,852
-658
-2% -$54K ﹤0.01% 339
2024
Q2
$3.69M Sell
32,510
-699
-2% -$88.4K 0.01% 297
2024
Q1
$4.61M Sell
33,209
-1,146
-3% -$144K 0.01% 293
2023
Q4
$4.26M Buy
34,355
+33,243
+2,989% +$3.4M 0.01% 298
2023
Q3
$104K Buy
1,112
+319
+40% +$36K ﹤0.01% 461
2023
Q2
$102K Sell
793
-154
-16% -$18.6K ﹤0.01% 460
2023
Q1
$110K Buy
947
+2
+0.2% +$224 ﹤0.01% 449
2022
Q4
$107K Buy
+945
New +$104K ﹤0.01% 460
2022
Q2
Sell
-28
Closed -$4K 622
2022
Q1
$4K Buy
28
+16
+133% +$1.75K ﹤0.01% 574
2021
Q4
$2K Buy
+12
New +$1.72K ﹤0.01% 586

Other funds holding DXCM

Kayne Anderson Rudnick Investment Management's DXCM Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its DexCom (DXCM) stake by 4.1% in Q2 2026, selling an estimated $119K and leaving 41,756 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #313.

Kayne Anderson Rudnick Investment Management first reported a position in DXCM in Q4 2021 and has held it in 17 quarters since. The position peaked at $4.61M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 41,756 shares of DexCom worth $2.81M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 1,793 DexCom shares in Q2 2026, an estimated $119K.
  • DexCom made up 0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #313 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in DexCom in Q4 2021 and has held it in 17 quarters since.
  • Kayne Anderson Rudnick Investment Management's DexCom position peaked at $4.61M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.